Lord, Abbett & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-412,677
Closed -$47M 654
2022
Q4
$47M Sell
412,677
-82,452
-17% -$9.38M 0.17% 174
2022
Q3
$30.6M Sell
495,129
-233,856
-32% -$14.5M 0.11% 246
2022
Q2
$58.1M Buy
728,985
+253,753
+53% +$20.2M 0.21% 136
2022
Q1
$50M Sell
475,232
-41,776
-8% -$4.4M 0.13% 222
2021
Q4
$55.7M Sell
517,008
-276,307
-35% -$29.8M 0.13% 239
2021
Q3
$86.9M Buy
793,315
+238,789
+43% +$26.2M 0.21% 155
2021
Q2
$51.9M Buy
554,526
+147,351
+36% +$13.8M 0.13% 249
2021
Q1
$37.5M Buy
407,175
+368,698
+958% +$33.9M 0.1% 313
2020
Q4
$2.82M Buy
38,477
+20,090
+109% +$1.47M 0.01% 616
2020
Q3
$1.43M Buy
+18,387
New +$1.43M ﹤0.01% 610
2015
Q2
Sell
-1,124,104
Closed -$29.2M 1016
2015
Q1
$29.2M Buy
+1,124,104
New +$29.2M 0.07% 389